Vaccines, Acellular

Name
Vaccines, Acellular
Accession Number
DBCAT005900
Description

Vaccines that are produced by using only the antigenic part of the disease causing organism. They often require a "booster" every few years to maintain their effectiveness.

Drugs
DrugDrug Description
CVnCoV VaccineThe CVnCov Vaccine (or CV07050101) is in development by CureVac AG. The vaccine uses mRNA technology to create a protein associated with SARS-CoV2, and upon administration and replication, to initiate...
FamtozinameranA component of a bivalent COVID-19 mRNA vaccine encoding the viral spike protein of Omicron variant lineages BA.4 and BA.5.
mRNA-1345mRNA-1345 is an investigational RSV vaccine.
Drugs & Drug Targets
DrugTargetType